Compared with placebo, fostamatinib did not increase the number of oxygen-free days among adults hospitalized with COVID-19 and hypoxemia.

Faster post-COVID-19 recovery is observed after infection with the Omicron vs earlier variants, regardless of vaccination status.

Discover how the severity of Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) evolved during successive COVID-19 waves, ...

The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.

The severity of multisystem inflammatory syndrome in children decreased as the COVID-19 pandemic went on, and most children ...

The study also evaluated the effectiveness of public health measures, such as travel restrictions, in reducing the spread ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

David Seymour’s 2025 State of the Nation speech has been overwhelmed with praise from those who attended and watched it ...

Delivered by ACT Leader David Seymour the Akarana Event Centre, Ōrākei.

In this study, the authors estimated that Paxlovid reduced the risk of hospitalization by 39% (95% confidence interval [CI], ...

According to a Washington State University study published this month, major apple-growing counties in the top three U.S.